Last close · 16 Oct 2026
Rs 128.65 -0.96%
Financials
BF Biosciences Limited (BFBIO) financials
7 years of annual results (FY2020 – FY2026), 13 quarters.
Return on equity was 12.7%.
Financial statements
Income statement
Revenue, costs, profit and earnings per share.
- Revenue · FY2026
- —
- Profit attributable · FY2026
- —
Balance sheet
Assets, liabilities, debt and shareholders' equity.
- Total assets · FY2026
- —
- Equity · FY2026
- —
Financial highlights
BFBIO financial results
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 |
|---|---|---|---|---|---|
| Revenue | — | 5,837.5 | 3,658.7 | 1,809.5 | 1,520.7 |
| Gross profit | — | 2,286.1 | 1,532.0 | 449.0 | 457.8 |
| Operating profit | 1,089.4 | 735.4 | 711.7 | 270.3 | 246.9 |
| Profit after tax | — | 447.1 | 385.4 | 149.1 | 307.0 |
| Profit attributable to shareholders | — | 447.1 | 385.4 | 149.1 | 307.0 |
| EPS – basic (Rs) Rs | — | 5.52 | 4.36 | 1.69 | 3.48 |
| Dividend per share (Rs) Rs | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Total assets | — | 8,158.5 | 5,860.0 | 5,666.8 | 4,435.1 |
| Total equity | — | 4,662.0 | 2,359.6 | 1,974.2 | 1,825.2 |
| Total debt | — | 1,724.8 | 2,212.3 | 2,602.7 | 1,744.1 |
| Net cash from operating activities | — | 282.6 | 519.5 | (232.9) | 292.0 |
| Capital expenditure | — | (329.5) | (143.1) | (1,970.0) | (1,130.2) |
| Free cash flow (operating cash flow − capex) | — | (46.9) | 376.4 | (2,203.0) | (838.1) |
| Rs bn | TTM to Jun 2026 | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 Apr – Jun 2025 | Q3 FY2025 Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2.1 | 2.7 | 2.4 | 1.6 | 1.5 | 1.3 | 1.4 |
| Gross profit | — | — | 1.0 | 1.2 | 1.0 | 0.6 | 0.5 | 0.6 | 0.6 |
| Operating profit | — | — | 0.2 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit after tax | — | — | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit attributable to shareholders | — | — | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| EPS – basic (Rs) Rs | — | — | 1.33 | 2.13 | 1.81 | 1.44 | 1.59 | 1.37 | 1.30 |
| Dividend per share (Rs) Rs | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total assets | — | — | 9.2 | 10.0 | 8.7 | 8.2 | 8.2 | 8.4 | 8.2 |
| Total equity | — | — | 5.1 | 5.0 | 4.8 | 4.7 | 4.5 | 4.4 | 2.5 |
| Total debt | — | — | 1.7 | 1.6 | 1.8 | 1.7 | 1.9 | 2.1 | 2.3 |
| Net cash from operating activities | — | — | (0.8) | 0.6 | 0.0 | 0.5 | (0.4) | 0.2 | 0.0 |
| Capital expenditure | — | — | (0.1) | (0.2) | (0.1) | (0.1) | (0.0) | (0.1) | (0.1) |
| Free cash flow (operating cash flow − capex) | — | — | (1.0) | 0.4 | (0.0) | 0.4 | (0.4) | 0.1 | (0.1) |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 16 Oct 2026.